Archive - December 2019
Gilead Submits Filgotinib New Drug Application to U.S. Food and Drug Administration Under Priority Review for Rheumatoid Arthritis Treatment
Seattle Genetics Announces Submission of Tucatinib New Drug Application to the U.S. FDA for Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer
BioMarin Submits Biologics License Application to U.S. Food and Drug Administration for Valoctocogene Roxaparvovec to Treat Hemophilia A
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
Q&A: Emma Sergeant
Lower Your Blood Pressure By Not Eating These 5 Foods
Keto Dieters Often Commit This Big Mistake, According To An Expert
How The Philippines Explored Uncharted Science Boundaries This 2019